For the third time since 2008, the University of Pittsburgh Medical Center (UPMC) Whitfield Cancer Centre, operated by UPMC in Waterford, Ireland, has successfully achieved accreditation from the Joint Commission International (JCI). This recognition is based on an extensive review of the center’s patient safety, quality standards, and processes.
The JCI accreditation process focuses on determining whether a health care facility has the right systems and processes in place to support high-quality and safe patient care and has the culture and capacity to continuously improve care. JCI’s surveyors examine crucial issues such as patient and family education, access to care, and medication management. The process requires hospitals to demonstrate a track record of standards compliance and relies on candid interviews with patients, nurses, and physicians about care practices.
“The success of this third accreditation survey reflects the ongoing efforts of the whole Cancer Centre team and their dedication to continuing to provide a quality service to all cancer patients,” said Catriona McDonald, Director of Operations and Radiotherapy Services Manager.
“Demonstrating compliance with JCI standards serves as validation of an organization’s commitment to an internationally recognized, time-tested, and comprehensive level of quality,” said Cheryl Brill, UPMC’s Vice President of International Clinical Operations and Quality.
UPMC Whitfield Cancer Centre offers the most advanced radiation therapy, including intensity-modulated radiation therapy and image-guided radiation therapy, to residents of the southeast region of Ireland. One of only four ambulatory care centers to be JCI-accredited in Ireland, the center is committed to delivering the highest standard of radiation therapy and supportive care for patients with all types of cancer. ■
